Shire Divests Eight “Non-Core” Products To Almirall For $213 Million
This article was originally published in The Pink Sheet Daily
Executive Summary
Deal, which includes Solaraze and Vaniqa, is in line with U.K. firm's strategy of focusing on development of specialty products.